This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hunt, S. C. Articles by Williams, R. R. Search for Related Content PubMed PubMed Citation Articles by Hunt, S. C. Articles by Williams, R. R.

Hypertension, Vol 17, 1-7, Copyright © 1991 by American Heart Association

ARTICLES

A prospective study of sodium-lithium countertransport and hypertension in Utah

SC Hunt, SH Stephenson, PN Hopkins, SJ Hasstedt and RR Williams
Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.

A 7-year prospective study of a cohort of 1,458 normotensive adults from Utah pedigrees, screened from 1980 to 1985, was done to determine whether baseline levels of sodium-lithium countertransport were associated with an increased risk of future hypertension. Subsequent new hypertension (n = 39) was ascertained in 1989 from detailed follow- up medical questionnaires (67% response). Previous segregation analyses on a subset of these pedigree members who responded (n = 342) using family relationships in addition to countertransport levels have shown statistically inferred major gene segregation of sodium-lithium countertransport levels. In the normotensive adults inferred by segregation analysis to carry the recessive major gene for high sodium- lithium countertransport, new-onset hypertension occurred in 18.8% (3 of 16) compared with 3.7% (12 of 326) in the low sodium-lithium countertransport genotype group (relative risk, 4.6 [1.6, 13.9]; p = 0.03). However, an elevated baseline sodium-lithium countertransport level without genotype information from segregation analysis did not increase the risk of future hypertension in the complete cohort of adult pedigree members (relative risk, 1.02 [0.85, 1.22]). Adjustment for other risk factors reduced the relative risk to 0.90 (0.72, 1.11). We conclude that the presence of a major gene for sodium-lithium countertransport or another closely linked gene, rather than the actual level of sodium-lithium countertransport, may increase the risk of hypertension onset. High sodium-lithium countertransport levels do not increase the risk of future hypertension for individuals in whom only polygenic and environmental effects determine sodium-lithium countertransport level.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				O. Vaccaro, V. Cuomo, M. Trevisan, M. Cirillo, W. Panarelli, M. Laurenzi, M. Mancini, G. Riccardi, and On behalf of the Gubbio Study Research Group Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes Int. J. Epidemiol., October 1, 2005; 34(5): 1123 - 1128. [Abstract] [Full Text] [PDF]

				G. Zerbini, A. Maestroni, D. Breviario, R. Mangili, and G. Casari Alternative Splicing of NHE-1 Mediates Na-Li Countertransport and Associates With Activity Rate Diabetes, June 1, 2003; 52(6): 1511 - 1518. [Abstract] [Full Text] [PDF]

				T. C. Hardman, M. I.M. Noble, C. M. Kammerer, L. A. Cox, and R. E. Shade Sodium-Lithium Countertransport Activity Is Linked to Chromosome 5 in Baboons Response Hypertension, December 1, 2001; 38 (6): e35 - e36. [Full Text] [PDF]

				J. Malakooti, R. Y. Dahdal, P. K. Dudeja, T. J. Layden, and K. Ramaswamy The human Na+/H+ exchanger NHE2 gene: genomic organization and promoter characterization Am J Physiol Gastrointest Liver Physiol, April 1, 2001; 280(4): G763 - G773. [Abstract] [Full Text] [PDF]

				P. Strazzullo, A. Siani, F. P. Cappuccio, M. Trevisan, E. Ragone, L. Russo, R. Iacone, and E. Farinaro Red Blood Cell Sodium-Lithium Countertransport and Risk of Future Hypertension : The Olivetti Prospective Heart Study Hypertension, June 1, 1998; 31(6): 1284 - 1289. [Abstract] [Full Text] [PDF]

				M. Laurenzi, M. Cirillo, W. Panarelli, M. Trevisan, R. Stamler, A. R. Dyer, and J. Stamler Baseline Sodium-Lithium Countertransport and 6-Year Incidence of Hypertension: The Gubbio Population Study Circulation, February 4, 1997; 95(3): 581 - 587. [Abstract] [Full Text]

				S. A. Yarows, W. E. Fusilier, and A. B. Weder Sodium Concentration of Water From Softeners Arch Intern Med, January 27, 1997; 157(2): 218 - 222. [Abstract] [PDF]

				J. Stamler Dietary Sodium and Blood Pressure JAMA, November 13, 1996; 276(18): 1467 - 1467. [Abstract] [PDF]

				C. K. Lardinois Nutritional Factors and Hypertension Arch Fam Med, August 1, 1995; 4(8): 707 - 713. [Abstract] [PDF]

				SHEP Cooperative Research Group Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension: Final Results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA, June 26, 1991; 265(24): 3255 - 3264. [Abstract] [PDF]